Agios Presents Updated PYRUKYND® (mitapivat) Data Highlighting Long-term Safety…
– Actively Enrolling Phase 3 ENERGIZE and ENERGIZE-T Studies Evaluating PYRUKYND® in Adults with Non-transfusion-dependent and Transfusion-dependent α- or β-Thalassemia, Respectively – –…